KENALOG-H Trademark

Trademark Overview

On Thursday, June 6, 2024, a trademark application was filed for KENALOG-H with the United States Patent and Trademark Office. The USPTO has given the KENALOG-H trademark a serial number of 98588635. The federal status of this trademark filing is REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION as of Thursday, March 13, 2025. This trademark is owned by Rising Pharma Holdings, Inc.. The KENALOG-H trademark is filed in the Pharmaceutical Products category with the following description:

Steroid preparations; corticosteroid preparations; glucocorticoid preparations
kenalog-h

General Information

Serial Number98588635
Word MarkKENALOG-H
Filing DateThursday, June 6, 2024
Status802 - REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION
Status DateThursday, March 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2025

Trademark Statements

Goods and ServicesSteroid preparations; corticosteroid preparations; glucocorticoid preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRising Pharma Holdings, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEast Brunswick, NJ 08816
Party NameRising Pharma Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEast Brunswick, NJ 08816

Trademark Events

Event DateEvent Description
Thursday, June 6, 2024NEW APPLICATION ENTERED
Tuesday, August 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 5, 2024ASSIGNED TO EXAMINER
Tuesday, November 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 6, 2024NON-FINAL ACTION E-MAILED
Wednesday, November 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 6, 2024NON-FINAL ACTION WRITTEN
Wednesday, November 6, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, January 28, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 31, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 31, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 31, 2025ASSIGNED TO LIE
Sunday, February 2, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 25, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, March 13, 2025EXTENSION OF TIME TO OPPOSE RECEIVED

Related Keywords

kenalog preparations glucocorticoid corticosteroid steroid